Molecular concepts analysis links tumors, pathways, mechanisms, and drugs

Daniel R Rhodes1, Shanker Kalyana-Sundaram, Scott A Tomlins

  • 1Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Neoplasia (New York, N.Y.)
|May 31, 2007
PubMed

Insights

This study integrates over 2500 cancer gene signatures to uncover over 290,000 associations between cancer types, pathways, and drugs. The Molecular Concepts Map platform aids in exploring these complex biological relationships for novel treatment insights.

Area of Science:

  • Cancer Research
  • Bioinformatics
  • Systems Biology

Background:

  • Global molecular profiling aids in understanding cancer pathways, prognosis, and treatment response.
  • Existing data requires integration to reveal deeper biological insights and therapeutic strategies.

Purpose of the Study:

  • To integrate and analyze a comprehensive collection of molecular concepts for cancer research.
  • To generate novel hypotheses linking cancer subtypes, pathways, mechanisms, and drugs.
  • To develop a platform for navigating complex molecular associations.

Main Methods:

  • Integrated >2500 cancer-related gene expression signatures from Oncomine and literature.
  • Incorporated drug treatment signatures from the Connectivity Map.
  • Utilized genome-scale regulatory motif analyses and annotation databases.
  • Performed pairwise association analysis on 13,364 molecular concepts.
  • Developed the Molecular Concepts Map analysis platform.

Main Results:

  • Identified >290,000 significant associations between molecular concepts.
  • Generated hypotheses linking cancer types, subtypes, pathways, mechanisms, and drugs.
  • Demonstrated utility through analyses of Myc pathway, breast cancer relapse, and retinoic acid treatment.

Conclusions:

  • The integrated molecular concept approach reveals extensive associations within cancer biology.
  • The Molecular Concepts Map facilitates exploration of complex biological networks.
  • This framework supports hypothesis generation for novel cancer therapies and understanding disease mechanisms.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...